SENSEX
NIFTY
GOLD
USD/INR

Weather

12    C

Health & Fitness / The Economic Times

Drug marketers to be held responsible for quality

Pharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product quality with the health and family welfare ministry on Thursday issuing a notification to this effect.

14 Feb 2020 8:00 am
Dr Reddys buys Wockhardts India business for Rs 1850 crore

The business comprises of a portfolio of 62 brands in multiple therapy areas such as Respiratory, Neurology, VMS,Dermatology, Pain and Vaccines, which would transfer to Dr Reddy's along with related sales and marketing teams and the manufacturing plant located in Baddi, Himachal Pradesh with all plant employees.

12 Feb 2020 1:25 pm
Premji Invest leads $126 million round in US company

Premji Invest, the investment firm of Wipros founder chairman Azim Premji, has led a $126 million funding in Boston-based primary care provider Iora Health. Existing investors Cox Enterprises, Temasek F-Prime Capital, Devonshire Investors, 406 Ventures, Flare Capital Partners, Polaris Partners, and Khosla Ventures participated in the round.

12 Feb 2020 11:14 am
Budget 2020: Hospital chains give thumbs up to viability gap fund

Analysts are upbeat that the proposed viability gap funding window for setting up hospitals in underserved areas will encourage hospital chains to offer services in tier 2 and 3 towns.

2 Feb 2020 1:54 pm
Budget 2020: Govt to launch campaign to eliminate TB by 2025, says FM Sitharaman

Presenting the Budget for 2020-21, Sitharaman proposed to expand Jan Aushadhi Kendras to all districts of the country to provide medicines at affordable rates.

1 Feb 2020 12:06 pm
Budget 2020: Govt to use proceeds from taxing medical devices for setting up hospitals in tier 2 and 3 cities

Finance minister Nirmala Sitharaman allocated Rs 69,000 crore, inclusive of Rs 6,400 crore for Jan Arogya Yojana, to healthcare in Budget 2020. This marks an increase from last year when she allocated Rs 62,659 crore.

1 Feb 2020 11:54 am
Government regulation led to increase in price of essential drugs: Economic Survey

Prices of those formulations, under price control, sold in hospitals increased as much as Rs 99 per mg, while those formulations which were not under price control and sold in hospitals, increased by only Rs 25 per mg.

31 Jan 2020 7:58 pm
Coronavirus pandemic threatens to cut pharmaceutical industrys lifeline

Raw materials from China are used in making antibiotics, paracetamol, and diabetes and cardiovascular drugs, among others. Companies including Lupin, Sun Pharmaceuticals, Glenmark, Mankind, Dr Reddys, Torrent, Aurobindo Pharma and Abbott are hugely dependent on Chinese imports.

30 Jan 2020 7:37 am
Torrent Pharmaceuticals puts faith in local market, to focus on new drug launches

The Ahmedabad-based company, part of the Rs 14,000-crore Torrent Group, is the only domestic pharma co that has invested nearly $1 bn in local acquisition over the last three years. Aman Mehta, chief marketing officer of Torrent Pharma said for now the focus of the co will be on launching new products in categories such as cardiology and diabetes.

29 Jan 2020 8:14 am
Cipla, PAG eye Wockhardts formulations business

Wockhardt employs more than 7,000 people and has a presence in the US, Britain, Ireland, Switzerland, France, Mexico, Russia and other countries. It has manufacturing and research facilities in India, the US and Britain, and a plant in Ireland.

28 Jan 2020 8:07 am
Digital healthcare wave

Artificial Intelligence AI has redefined the healthcare sector in UAE, and has the potential to boost global GDP by 14 per cent by 2030 Science and techno...

24 Jan 2020 7:55 pm
Smart Group to invest Rs 2,000 crore to open wellness city in Delhi

B K Modi-led Smart Group plans to invest around Rs 2,000 crore to open a wellness city in Delhi by 2025 as it bets big on the sector globally, a top company official said.

22 Jan 2020 1:49 pm
18% of Indian pharma launches to be delayed in US, says Crisil

The warning letter issued by USFDA to large pharma companies more than doubled in the first 10 months of 2019 compared with the previous year, CRISIL said, adding that close to 180 generic drug launches will be pushed out from their intended launch dates due to it.

22 Jan 2020 7:19 am